| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/ES1043613 |
| P698 | PubMed publication ID | 21469664 |
| P50 | author | Antonia M. Calafat | Q28656527 |
| P2093 | author name string | Lee-Yang Wong | |
| Lily T Jia | |||
| Kayoko Kato | |||
| Zsuzsanna Kuklenyik | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8037-8045 | |
| P577 | publication date | 2011-04-06 | |
| P1433 | published in | Environmental Science & Technology | Q689027 |
| P1476 | title | Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. | |
| P478 | volume | 45 |
| Q41559585 | A cohort incidence study of workers exposed to perfluorooctanoic acid (PFOA). |
| Q28394965 | A comparison of temporal trends in United States autism prevalence to trends in suspected environmental factors |
| Q38209158 | A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humans |
| Q28072372 | A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humans |
| Q28394407 | A method to screen U.S. environmental biomonitoring data for race/ethnicity and income-related disparity |
| Q28385335 | A prospective study of prepregnancy serum concentrations of perfluorochemicals and the risk of gestational diabetes |
| Q93336503 | A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects |
| Q50026411 | Alteration of bile acid and cholesterol biosynthesis and transport by perfluorononanoic acid (PFNA) in mice. |
| Q40276868 | An ultra-sensitive method for the analysis of perfluorinated alkyl acids in drinking water using a column switching high-performance liquid chromatography tandem mass spectrometry |
| Q36539348 | Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates |
| Q55331831 | Association between perfluoroalkyl substances exposure and thyroid function in adults: A meta-analysis. |
| Q28396658 | Association of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2008 |
| Q36456151 | Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010 |
| Q64132490 | Association of Perfluoroalkyl and Polyfluoroalkyl Substances With Adiposity |
| Q58080051 | Associations between longitudinal serum perfluoroalkyl substance (PFAS) levels and measures of thyroid hormone, kidney function, and body mass index in the Fernald Community Cohort |
| Q99556536 | Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs) and birth outcomes among pregnant women in San Francisco |
| Q34273620 | Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation |
| Q35250864 | Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort |
| Q35102612 | Autoantibodies associated with prenatal and childhood exposure to environmental chemicals in Faroese children |
| Q51779216 | Behavioral, morphometric, and gene expression effects in adult zebrafish (Danio rerio) embryonically exposed to PFOA, PFOS, and PFNA. |
| Q64137318 | Biomarkers of exposure to SVOCs in children and their demographic associations: The TESIE Study |
| Q93153844 | Biomonitoring of populations in Western New York at risk for exposure to Great Lakes contaminants |
| Q59806739 | Breast cancer risk and serum levels of per- and poly-fluoroalkyl substances: a case-control study nested in the California Teachers Study |
| Q49483102 | Can profiles of poly- and Perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources? |
| Q91885451 | Can sustained exposure to PFAS trigger a genotoxic response? A comprehensive genotoxicity assessment in mice after subacute oral administration of PFOA and PFBA |
| Q55517871 | Changes in plasma levels of perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness over 10 years - a longitudinal study. |
| Q34074733 | Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006. |
| Q34296310 | Changing interpretation of human health risks from perfluorinated compounds |
| Q77790626 | Characterization of age-based trends to identify chemical biomarkers of higher levels in children |
| Q42700658 | Chronic Exposure of Female Mice to an Environmental Level of Perfluorooctane Sulfonate Suppresses Estrogen Synthesis Through Reduced Histone H3K14 Acetylation of the StAR Promoter Leading to Deficits in Follicular Development and Ovulation |
| Q62091444 | Concentrations of endocrine disrupting chemicals in newborn blood spots and infant outcomes in the upstate KIDS study |
| Q35544436 | Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements |
| Q77791728 | Cord blood perfluoroalkyl substances in mothers exposed to the World Trade Center disaster during pregnancy |
| Q37077698 | Cross-Sectional Associations of Serum Perfluoroalkyl Acids and Thyroid Hormones in U.S. Adults: Variation According to TPOAb and Iodine Status (NHANES 2007-2008). |
| Q36856193 | Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey |
| Q64247225 | Cross-sectional study of the association between serum perfluorinated alkyl acid concentrations and dental caries among US adolescents (NHANES 1999-2012) |
| Q49843499 | Cumulative exposure to environmental pollutants during early pregnancy and reduced fetal growth: the Project Viva cohort |
| Q36493916 | Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011. |
| Q77790988 | Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: evidence of racial/ethnic and geographic differences in PFAS exposure |
| Q52647308 | Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes. |
| Q60284100 | Developmental Origins of Disease: Emerging Prenatal Risk Factors and Future Disease Risk |
| Q48607334 | Distribution of perfluoroalkyl compounds in rats: Indication for using hair as bioindicator of exposure |
| Q47789399 | Early Pregnancy Perfluoroalkyl Substance Plasma Concentrations and Birth Outcomes in Project Viva: Confounded by Pregnancy Hemodynamics? |
| Q99623638 | Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects |
| Q38833921 | Early-life exposures to persistent organic pollutants in relation to overweight in preschool children. |
| Q36239549 | Effect of temperature and duration of storage on the stability of polyfluoroalkyl chemicals in human serum |
| Q36754614 | Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse Revealed by a High-throughput Targeted Metabolomics Approach |
| Q50940268 | Effects of perfluorinated chemicals on thyroid function, markers of ovarian reserve, and natural fertility. |
| Q37639340 | Environmental Factors Impacting Bone-Relevant Chemokines. |
| Q92145016 | Environmental chemical exposures among Greenlandic children in relation to diet and residence |
| Q44553737 | Environmental toxicity of PFCs: an enhanced integrated biomarker assessment and structure-activity analysis |
| Q51067944 | Estrogen receptor beta mediates hepatotoxicity induced by perfluorooctane sulfonate in mouse. |
| Q89722945 | Evaluating thyroid hormone disruption: investigations of long-term neurodevelopmental effects in rats after perinatal exposure to perfluorohexane sulfonate (PFHxS) |
| Q89779976 | Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX) |
| Q41681441 | Evaluation of perfluorooctanoate for potential genotoxicity |
| Q90743664 | Exposome-wide association study of semen quality: Systematic discovery of endocrine disrupting chemical biomarkers in fertility require large sample sizes |
| Q39400487 | Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature |
| Q28383912 | Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant |
| Q50043714 | Exposure to perfluoroalkyl substances during pregnancy and child behaviour at 5 to 9years of age. |
| Q28553267 | Factors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and Sweden |
| Q61999224 | Fluorinated Compounds in U.S. Fast Food Packaging |
| Q47197494 | Gestational diabetes and offspring birth size at elevated environmental pollutant exposures |
| Q64928041 | Grape seed proanthocyanidin extract protects against perfluorooctanoic acid-induced hepatotoxicity by attenuating inflammatory response, oxidative stress and apoptosis in mice. |
| Q47287240 | Identification of Biomarkers of Exposure to FTOHs and PAPs in Humans Using a Targeted and Nontargeted Analysis Approach |
| Q59566813 | Identification of metabolic profiles associated with human exposure to perfluoroalkyl substances |
| Q51544305 | Identification of protein tyrosine phosphatase SHP-2 as a new target of perfluoroalkyl acids in HepG2 cells. |
| Q35008020 | In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL-2 production in human T-cells |
| Q36493907 | Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate |
| Q34224120 | Input characterization of perfluoroalkyl substances in wastewater treatment plants: source discrimination by exploratory data analysis |
| Q35673553 | Involvement of NRF2 in Perfluorooctanoic Acid-Induced Testicular Damage in Male Mice |
| Q35145873 | Involvement of oxidative stress and inflammation in liver injury caused by perfluorooctanoic acid exposure in mice |
| Q35579871 | Isomer profiles of perfluorochemicals in matched maternal, cord, and house dust samples: manufacturing sources and transplacental transfer |
| Q40686061 | Lactation history, serum concentrations of persistent organic pollutants, and maternal risk of diabetes |
| Q46632573 | Levels of persistent contaminants in relation to fish consumption among older male anglers in Wisconsin |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q51035022 | Maternal and paternal serum concentrations of perfluoroalkyl and polyfluoroalkyl substances and the secondary sex ratio. |
| Q35076573 | Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study |
| Q64125808 | Maternal serum concentrations of perfluoroalkyl substances and birth size in British boys |
| Q60126442 | Measuring total PFASs in water: The tradeoff between selectivity and inclusivity |
| Q59156231 | Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study) |
| Q28383653 | Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts |
| Q23915929 | Mortality and cancer incidence in ammonium perfluorooctanoate production workers |
| Q36167561 | Na+/Taurocholate Cotransporting Polypeptide and Apical Sodium-Dependent Bile Acid Transporter Are Involved in the Disposition of Perfluoroalkyl Sulfonates in Humans and Rats |
| Q37997949 | Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance |
| Q47806217 | Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study |
| Q38674594 | Occurrence and incidence of 18 per- and polyfluoroalkyl compounds in edible oils commonly consumed in Guiyang, China |
| Q90317708 | Occurrence, partition and environmental risk assessment of per- and polyfluoroalkyl substances in water and sediment from the Baiyangdian Lake, China |
| Q51734932 | Organic Anion Transporting Polypeptides Contribute to the Disposition of Perfluoroalkyl Acids in Humans and Rats. |
| Q43056011 | PFOA and high cholesterol: basis for the finding of a probable link |
| Q38068391 | PFOS (perfluorooctanesulfonate) in serum is negatively associated with testosterone levels, but not with semen quality, in healthy men. |
| Q47885418 | PTFE-coated non-stick cookware and toxicity concerns: a perspective |
| Q28385043 | Paternal exposures to environmental chemicals and time-to-pregnancy: overview of results from the LIFE study |
| Q90379905 | Patterns and Variability of Endocrine-disrupting Chemicals During Pregnancy: Implications for Understanding the Exposome of Normal Pregnancy |
| Q93350965 | Per and polyfluoroalkyl substances (PFAS) blood levels after contamination of a community water supply and comparison with 2013-2014 NHANES |
| Q99596520 | Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva |
| Q100444139 | Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research |
| Q96955204 | Per- and poly-fluoroalkyl substances and bone mineral density: Results from the Bayesian weighted quantile sum regression |
| Q64137295 | Per- and polyfluoroalkyl substances and fluorinated alternatives in urine and serum by on-line solid phase extraction-liquid chromatography-tandem mass spectrometry |
| Q89134221 | Per- and polyfluoroalkyl substances impact human spermatogenesis in a stem-cell-derived model |
| Q38711850 | Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community |
| Q38530449 | Perfluorinated Alkyl Substances: Emerging Insights Into Health Risks. |
| Q37668109 | Perfluorinated alkyl substances in serum of the southern Chinese general population and potential impact on thyroid hormones |
| Q28395499 | Perfluoroalkyl Chemicals, Menstrual Cycle Length, and Fecundity: Findings from a Prospective Pregnancy Study |
| Q40137662 | Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study |
| Q28831121 | Perfluoroalkyl Substances, Sex Hormones, and Insulin-like Growth Factor-1 at 6-9 Years of Age: A Cross-Sectional Analysis within the C8 Health Project |
| Q53131736 | Perfluoroalkyl acids and Time-to-Pregnancy: The issue of "parity-conditioning bias". |
| Q38265262 | Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review |
| Q37341106 | Perfluoroalkyl and polyfluoroalkyl substances and indicators of immune function in children aged 12-19 y: National Health and Nutrition Examination Survey. |
| Q30666605 | Perfluoroalkyl and polyfluoroalkyl substances in consumer products. |
| Q34275281 | Perfluoroalkyl chemicals and asthma among children 12-19 years of age: NHANES (1999-2008). |
| Q40743240 | Perfluoroalkyl substance serum concentrations and immune response to FluMist vaccination among healthy adults |
| Q50041743 | Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study |
| Q90591355 | Perfluoroalkyl substances and changes in bone mineral density: A prospective analysis in the POUNDS-LOST study |
| Q37408761 | Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study |
| Q35562877 | Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women |
| Q34749100 | Perfluoroalkyl substances and thyroid function in older adults |
| Q40251746 | Perfluoroalkyl substances with isomer analysis in umbilical cord serum in China. |
| Q34004281 | Perfluorochemicals and endometriosis: the ENDO study |
| Q28385518 | Perfluorochemicals and human semen quality: the LIFE study |
| Q33984406 | Perfluorooctanoate exposure and major birth defects |
| Q36198328 | Perfluorooctanoate exposure in a highly exposed community and parent and teacher reports of behaviour in 6-12-year-old children |
| Q35607167 | Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required |
| Q35874820 | Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community |
| Q38728291 | Perfluorooctanoic acid induces mitochondrial dysfunction in MC3T3-E1 osteoblast cells |
| Q50042998 | Persistent alterations in immune cell populations and function from a single dose of perfluorononanoic acid (PFNA) in C57Bl/6 mice |
| Q28394271 | Persistent environmental pollutants and couple fecundity: the LIFE study |
| Q38690520 | Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations |
| Q36602609 | Placental Transfer of Perfluoroalkyl Substances and Associations with Thyroid Hormones: Beijing Prenatal Exposure Study |
| Q51246138 | Plasma Concentrations of Perfluoroalkyl Substances and Risk of Type 2 Diabetes: A Prospective Investigation among U.S. Women. |
| Q46988860 | Poly- and perfluoroalkyl substances in wastewater: Significance of unknown precursors, manufacturing shifts, and likely AFFF impacts. |
| Q45230914 | Polybrominated diphenyl ethers and perfluoroalkyl substances in serum of pregnant women: levels, correlations, and potential health implications |
| Q37523530 | Polyfluorinated compounds in dust from homes, offices, and vehicles as predictors of concentrations in office workers' serum |
| Q37559515 | Polyfluoroalkyl chemicals and menopause among women 20-65 years of age (NHANES). |
| Q35920263 | Polyfluoroalkyl compounds in Texas children from birth through 12 years of age. |
| Q86391809 | Polyfluoroalkyl phosphate esters and perfluoroalkyl carboxylic acids in target food samples and packaging--method development and screening |
| Q42277537 | Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood |
| Q28391766 | Preconception perfluoroalkyl and polyfluoroalkyl substances and incident pregnancy loss, LIFE Study |
| Q38889149 | Predictors of Per- and Polyfluoroalkyl Substance (PFAS) Plasma Concentrations in 6-10 Year Old American Children |
| Q36350887 | Prenatal Exposure to Perfluoroalkyl Acids and Serum Testosterone Concentrations at 15 Years of Age in Female ALSPAC Study Participants |
| Q36938040 | Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children |
| Q57167619 | Prenatal Exposure to Perfluoroalkyl Substances and Birth Outcomes; An Updated Analysis from the Danish National Birth Cohort |
| Q89089334 | Prenatal Exposure to Perfluoroalkyl Substances and IQ Scores at Age 5; a Study in the Danish National Birth Cohort |
| Q37385404 | Prenatal Exposure to Perfluorocarboxylic Acids (PFCAs) and Fetal and Postnatal Growth in the Taiwan Maternal and Infant Cohort Study |
| Q49342317 | Prenatal Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances in Association with Autism Spectrum Disorder and Intellectual Disability |
| Q64137911 | Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition |
| Q47552199 | Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study |
| Q35941792 | Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study |
| Q46251233 | Proposal for coordinated health research in PFAS-contaminated communities in the United States |
| Q28384774 | Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population |
| Q34240592 | Public health concern behind the exposure to persistent organic pollutants and the risk of metabolic diseases |
| Q37057606 | Recent developments in methods for analysis of perfluorinated persistent pollutants |
| Q93160224 | Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota |
| Q36493895 | Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid |
| Q36453518 | Regional Variation in Human Exposure to Persistent Organic Pollutants in the United States, NHANES. |
| Q37515730 | Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology |
| Q47878689 | Relationship between peroxisome proliferator-activated receptor alpha activity and cellular concentration of 14 perfluoroalkyl substances in HepG2 cells. |
| Q35941864 | Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water |
| Q28397823 | Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnancies |
| Q35790907 | Serum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011-2012. |
| Q90950137 | Serum concentrations of PFASs and exposure-related behaviors in African American and non-Hispanic white women |
| Q45376606 | Serum concentrations of perfluorinated alkyl acids and their associations with diet and personal characteristics among Swedish adults |
| Q36493920 | Serum concentrations of perfluorinated compounds (PFC) among selected populations of children and adults in California |
| Q48001741 | Serum perfluoroalkyl acids (PFAAs) and associations with behavioral attributes |
| Q36939320 | Serum perfluoroalkyl acids concentrations and memory impairment in a large cross-sectional study |
| Q35941855 | Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. |
| Q36751014 | Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children |
| Q47578009 | Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model. |
| Q36264053 | Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations |
| Q38719346 | Spatial and temporal trends of poly- and perfluoroalkyl substances in fish fillets and water collected from pool 2 of the Upper Mississippi River |
| Q41595188 | State of the evidence 2017: an update on the connection between breast cancer and the environment |
| Q90697809 | Temporal Trends (1981-2013) of Per- and Polyfluoroalkyl Substances and Total Fluorine in Baltic cod (Gadus morhua) |
| Q42712587 | Testing for departures from additivity in mixtures of perfluoroalkyl acids (PFAAs). |
| Q37286520 | Testosterone-Mediated Endocrine Function and TH1/TH2 Cytokine Balance after Prenatal Exposure to Perfluorooctane Sulfonate: By Sex Status. |
| Q90179162 | The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood |
| Q26851809 | The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth |
| Q34275308 | The Navigation Guide - evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth |
| Q30241400 | Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA). |
| Q36115374 | Thyroid function and perfluoroalkyl acids in children living near a chemical plant |
| Q52690095 | Thyroid-disrupting chemicals and brain development: an update. |
| Q43309321 | Treatment of poly- and perfluoroalkyl substances in U.S. full-scale water treatment systems |
| Q40570436 | Trends in Exposure to Chemicals in Personal Care and Consumer Products |
| Q93063067 | Type 1 diabetes-early life origins and changing epidemiology |
| Q64137858 | Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood |
| Q37931225 | Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals |
Search more.